世界のマントル細胞リンパ腫治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Mantle Cell Lymphoma Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5839 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、マントル細胞リンパ腫治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（病院、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・マントル細胞リンパ腫治療薬の市場動向 ・企業の競争状況、市場シェア ・マントル細胞リンパ腫治療薬の種類別市場規模と予測2016-2027（併用療法、単剤療法） ・マントル細胞リンパ腫治療薬の用途別市場規模と予測2016-2027（病院、研究所、その他） ・マントル細胞リンパ腫治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・マントル細胞リンパ腫治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・マントル細胞リンパ腫治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・マントル細胞リンパ腫治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・マントル細胞リンパ腫治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan Plc、AstraZeneca Plc、Celgene Corp.、Johnson & Johnson Services Inc.、Takeda Pharmaceutical Co. Ltd.） ・結論

Mantle cell lymphoma (MCL) is a heterogeneous aggressive disease and remains incurable with current chemotherapies. The development of monoclonal antibody (mAb) has led to substantial achievement in immunotherapeutic strategies for B-cell lymphomas including MCL.
Nonetheless, progress in the clinical use of mAbs is hindered by poor efficacy, off-target toxicities and drug resistance. Thus, novel mAbs engineering and approaches to improve target specificity and enhance affinity and potency are required.

Market Analysis and Insights: Global Mantle Cell Lymphoma Therapeutics Market
The global Mantle Cell Lymphoma Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mantle Cell Lymphoma Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mantle Cell Lymphoma Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mantle Cell Lymphoma Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mantle Cell Lymphoma Therapeutics market.

Global Mantle Cell Lymphoma Therapeutics Scope and Market Size
Mantle Cell Lymphoma Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mantle Cell Lymphoma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Combination Therapy
Monotherapy

Segment by Application
Hospital
Research Institute
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan Plc
AstraZeneca Plc
Celgene Corp.
Johnson & Johnson Services Inc.
Takeda Pharmaceutical Co. Ltd.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mantle Cell Lymphoma Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Combination Therapy
1.2.3 Monotherapy
1.3 Market by Application
1.3.1 Global Mantle Cell Lymphoma Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Mantle Cell Lymphoma Therapeutics Market Perspective (2016-2027)
2.2 Mantle Cell Lymphoma Therapeutics Growth Trends by Regions
2.2.1 Mantle Cell Lymphoma Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Mantle Cell Lymphoma Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Mantle Cell Lymphoma Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Mantle Cell Lymphoma Therapeutics Industry Dynamic
2.3.1 Mantle Cell Lymphoma Therapeutics Market Trends
2.3.2 Mantle Cell Lymphoma Therapeutics Market Drivers
2.3.3 Mantle Cell Lymphoma Therapeutics Market Challenges
2.3.4 Mantle Cell Lymphoma Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Mantle Cell Lymphoma Therapeutics Players by Revenue
3.1.1 Global Top Mantle Cell Lymphoma Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Mantle Cell Lymphoma Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Mantle Cell Lymphoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Mantle Cell Lymphoma Therapeutics Revenue
3.4 Global Mantle Cell Lymphoma Therapeutics Market Concentration Ratio
3.4.1 Global Mantle Cell Lymphoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mantle Cell Lymphoma Therapeutics Revenue in 2020
3.5 Mantle Cell Lymphoma Therapeutics Key Players Head office and Area Served
3.6 Key Players Mantle Cell Lymphoma Therapeutics Product Solution and Service
3.7 Date of Enter into Mantle Cell Lymphoma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Mantle Cell Lymphoma Therapeutics Breakdown Data by Type
4.1 Global Mantle Cell Lymphoma Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Mantle Cell Lymphoma Therapeutics Forecasted Market Size by Type (2022-2027)

5 Mantle Cell Lymphoma Therapeutics Breakdown Data by Application
5.1 Global Mantle Cell Lymphoma Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Mantle Cell Lymphoma Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Mantle Cell Lymphoma Therapeutics Market Size (2016-2027)
6.2 North America Mantle Cell Lymphoma Therapeutics Market Size by Type
6.2.1 North America Mantle Cell Lymphoma Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Mantle Cell Lymphoma Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Mantle Cell Lymphoma Therapeutics Market Size by Type (2016-2027)
6.3 North America Mantle Cell Lymphoma Therapeutics Market Size by Application
6.3.1 North America Mantle Cell Lymphoma Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Mantle Cell Lymphoma Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Mantle Cell Lymphoma Therapeutics Market Size by Application (2016-2027)
6.4 North America Mantle Cell Lymphoma Therapeutics Market Size by Country
6.4.1 North America Mantle Cell Lymphoma Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Mantle Cell Lymphoma Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Mantle Cell Lymphoma Therapeutics Market Size (2016-2027)
7.2 Europe Mantle Cell Lymphoma Therapeutics Market Size by Type
7.2.1 Europe Mantle Cell Lymphoma Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Mantle Cell Lymphoma Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Mantle Cell Lymphoma Therapeutics Market Size by Type (2016-2027)
7.3 Europe Mantle Cell Lymphoma Therapeutics Market Size by Application
7.3.1 Europe Mantle Cell Lymphoma Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Mantle Cell Lymphoma Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Mantle Cell Lymphoma Therapeutics Market Size by Application (2016-2027)
7.4 Europe Mantle Cell Lymphoma Therapeutics Market Size by Country
7.4.1 Europe Mantle Cell Lymphoma Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Mantle Cell Lymphoma Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size by Type
8.2.1 Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size by Application
8.3.1 Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size by Region
8.4.1 Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Mantle Cell Lymphoma Therapeutics Market Size (2016-2027)
9.2 Latin America Mantle Cell Lymphoma Therapeutics Market Size by Type
9.2.1 Latin America Mantle Cell Lymphoma Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Mantle Cell Lymphoma Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Mantle Cell Lymphoma Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Mantle Cell Lymphoma Therapeutics Market Size by Application
9.3.1 Latin America Mantle Cell Lymphoma Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Mantle Cell Lymphoma Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Mantle Cell Lymphoma Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Mantle Cell Lymphoma Therapeutics Market Size by Country
9.4.1 Latin America Mantle Cell Lymphoma Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Mantle Cell Lymphoma Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size by Type
10.2.1 Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size by Application
10.3.1 Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size by Country
10.4.1 Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan Plc
11.1.1 Allergan Plc Company Details
11.1.2 Allergan Plc Business Overview
11.1.3 Allergan Plc Mantle Cell Lymphoma Therapeutics Introduction
11.1.4 Allergan Plc Revenue in Mantle Cell Lymphoma Therapeutics Business (2016-2021)
11.1.5 Allergan Plc Recent Development
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Details
11.2.2 AstraZeneca Plc Business Overview
11.2.3 AstraZeneca Plc Mantle Cell Lymphoma Therapeutics Introduction
11.2.4 AstraZeneca Plc Revenue in Mantle Cell Lymphoma Therapeutics Business (2016-2021)
11.2.5 AstraZeneca Plc Recent Development
11.3 Celgene Corp.
11.3.1 Celgene Corp. Company Details
11.3.2 Celgene Corp. Business Overview
11.3.3 Celgene Corp. Mantle Cell Lymphoma Therapeutics Introduction
11.3.4 Celgene Corp. Revenue in Mantle Cell Lymphoma Therapeutics Business (2016-2021)
11.3.5 Celgene Corp. Recent Development
11.4 Johnson & Johnson Services Inc.
11.4.1 Johnson & Johnson Services Inc. Company Details
11.4.2 Johnson & Johnson Services Inc. Business Overview
11.4.3 Johnson & Johnson Services Inc. Mantle Cell Lymphoma Therapeutics Introduction
11.4.4 Johnson & Johnson Services Inc. Revenue in Mantle Cell Lymphoma Therapeutics Business (2016-2021)
11.4.5 Johnson & Johnson Services Inc. Recent Development
11.5 Takeda Pharmaceutical Co. Ltd.
11.5.1 Takeda Pharmaceutical Co. Ltd. Company Details
11.5.2 Takeda Pharmaceutical Co. Ltd. Business Overview
11.5.3 Takeda Pharmaceutical Co. Ltd. Mantle Cell Lymphoma Therapeutics Introduction
11.5.4 Takeda Pharmaceutical Co. Ltd. Revenue in Mantle Cell Lymphoma Therapeutics Business (2016-2021)
11.5.5 Takeda Pharmaceutical Co. Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Mantle Cell Lymphoma Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Combination Therapy
Table 3. Key Players of Monotherapy
Table 4. Global Mantle Cell Lymphoma Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Mantle Cell Lymphoma Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Mantle Cell Lymphoma Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Mantle Cell Lymphoma Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Mantle Cell Lymphoma Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Mantle Cell Lymphoma Therapeutics Market Share by Regions (2022-2027)
Table 10. Mantle Cell Lymphoma Therapeutics Market Trends
Table 11. Mantle Cell Lymphoma Therapeutics Market Drivers
Table 12. Mantle Cell Lymphoma Therapeutics Market Challenges
Table 13. Mantle Cell Lymphoma Therapeutics Market Restraints
Table 14. Global Mantle Cell Lymphoma Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Mantle Cell Lymphoma Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Mantle Cell Lymphoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mantle Cell Lymphoma Therapeutics as of 2020)
Table 17. Ranking of Global Top Mantle Cell Lymphoma Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Mantle Cell Lymphoma Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Mantle Cell Lymphoma Therapeutics Product Solution and Service
Table 21. Date of Enter into Mantle Cell Lymphoma Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Mantle Cell Lymphoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Mantle Cell Lymphoma Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Mantle Cell Lymphoma Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Mantle Cell Lymphoma Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Mantle Cell Lymphoma Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Mantle Cell Lymphoma Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Mantle Cell Lymphoma Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Mantle Cell Lymphoma Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Mantle Cell Lymphoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Mantle Cell Lymphoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Mantle Cell Lymphoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Mantle Cell Lymphoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Mantle Cell Lymphoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Mantle Cell Lymphoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Mantle Cell Lymphoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Mantle Cell Lymphoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Mantle Cell Lymphoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Mantle Cell Lymphoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Mantle Cell Lymphoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Mantle Cell Lymphoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Mantle Cell Lymphoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Mantle Cell Lymphoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Mantle Cell Lymphoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Mantle Cell Lymphoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Mantle Cell Lymphoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Mantle Cell Lymphoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Allergan Plc Company Details
Table 62. Allergan Plc Business Overview
Table 63. Allergan Plc Mantle Cell Lymphoma Therapeutics Product
Table 64. Allergan Plc Revenue in Mantle Cell Lymphoma Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Allergan Plc Recent Development
Table 66. AstraZeneca Plc Company Details
Table 67. AstraZeneca Plc Business Overview
Table 68. AstraZeneca Plc Mantle Cell Lymphoma Therapeutics Product
Table 69. AstraZeneca Plc Revenue in Mantle Cell Lymphoma Therapeutics Business (2016-2021) & (US$ Million)
Table 70. AstraZeneca Plc Recent Development
Table 71. Celgene Corp. Company Details
Table 72. Celgene Corp. Business Overview
Table 73. Celgene Corp. Mantle Cell Lymphoma Therapeutics Product
Table 74. Celgene Corp. Revenue in Mantle Cell Lymphoma Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Celgene Corp. Recent Development
Table 76. Johnson & Johnson Services Inc. Company Details
Table 77. Johnson & Johnson Services Inc. Business Overview
Table 78. Johnson & Johnson Services Inc. Mantle Cell Lymphoma Therapeutics Product
Table 79. Johnson & Johnson Services Inc. Revenue in Mantle Cell Lymphoma Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Johnson & Johnson Services Inc. Recent Development
Table 81. Takeda Pharmaceutical Co. Ltd. Company Details
Table 82. Takeda Pharmaceutical Co. Ltd. Business Overview
Table 83. Takeda Pharmaceutical Co. Ltd. Mantle Cell Lymphoma Therapeutics Product
Table 84. Takeda Pharmaceutical Co. Ltd. Revenue in Mantle Cell Lymphoma Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Takeda Pharmaceutical Co. Ltd. Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mantle Cell Lymphoma Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Combination Therapy Features
Figure 3. Monotherapy Features
Figure 4. Global Mantle Cell Lymphoma Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Research Institute Case Studies
Figure 7. Other Case Studies
Figure 8. Mantle Cell Lymphoma Therapeutics Report Years Considered
Figure 9. Global Mantle Cell Lymphoma Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Mantle Cell Lymphoma Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Mantle Cell Lymphoma Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Mantle Cell Lymphoma Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Mantle Cell Lymphoma Therapeutics Market Share by Players in 2020
Figure 14. Global Top Mantle Cell Lymphoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mantle Cell Lymphoma Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Mantle Cell Lymphoma Therapeutics Revenue in 2020
Figure 16. Global Mantle Cell Lymphoma Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Mantle Cell Lymphoma Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Mantle Cell Lymphoma Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Mantle Cell Lymphoma Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Mantle Cell Lymphoma Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Mantle Cell Lymphoma Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Mantle Cell Lymphoma Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Mantle Cell Lymphoma Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Mantle Cell Lymphoma Therapeutics Market Share by Region (2016-2027)
Figure 38. China Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Mantle Cell Lymphoma Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Mantle Cell Lymphoma Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Mantle Cell Lymphoma Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Mantle Cell Lymphoma Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Mantle Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Allergan Plc Revenue Growth Rate in Mantle Cell Lymphoma Therapeutics Business (2016-2021)
Figure 58. AstraZeneca Plc Revenue Growth Rate in Mantle Cell Lymphoma Therapeutics Business (2016-2021)
Figure 59. Celgene Corp. Revenue Growth Rate in Mantle Cell Lymphoma Therapeutics Business (2016-2021)
Figure 60. Johnson & Johnson Services Inc. Revenue Growth Rate in Mantle Cell Lymphoma Therapeutics Business (2016-2021)
Figure 61. Takeda Pharmaceutical Co. Ltd. Revenue Growth Rate in Mantle Cell Lymphoma Therapeutics Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

---